Genetic and Histopathologic Characteristics of Interstitial Cystitis
Sponsor
Samsung Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT03523559
Collaborator
(none)
15
1
44.1
0.3
Study Details
Study Description
Brief Summary
Genetic and Histopathologic Characteristics of Interstitial Cystitis
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
15 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Genetic and Histopathologic Characteristics of Interstitial Cystitis
Actual Study Start Date
:
Mar 31, 2018
Anticipated Primary Completion Date
:
Dec 1, 2021
Anticipated Study Completion Date
:
Dec 1, 2021
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Interstitial Cystitis
|
Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue
Obtain the bladder tissue of Interstitial Cystitis and normal during the operation
|
| normal
|
Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue
Obtain the bladder tissue of Interstitial Cystitis and normal during the operation
|
Outcome Measures
Primary Outcome Measures
- Genetic differences between ulcer and non-ulcer of bladder in Interstitial Cystitis [30days]
- Genetic differences between bladder tissue of Interstitial Cystitis and normal bladder tissue [30days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Male and female aged 19 yrs or greater
-
Patients diagnosed with Hunner lesion in Interstitial cystitis and who is scheduled to undergo transurethral resection
-
Patients diagnosed with Bladder cancer and who is scheduled to undergo cystectomy
Exclusion Criteria:
-
Male and female under aged 20 yrs
-
A person whose area of bladder cancer is larger than that of the normal area
-
A person who is going to have a cystectomy after chemotherapy on bladder cancer
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Samsung Medical Center, Sungkyunkwan University School of Medicine | Seoul | Korea, Republic of | 135-710 |
Sponsors and Collaborators
- Samsung Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
KYU-SUNG LEE,
professor,
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT03523559
Other Study ID Numbers:
- 2018-03-025
First Posted:
May 14, 2018
Last Update Posted:
Sep 20, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: